Mitsuru Okubo
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Diagnostic and Prognostic Applications of PET/CT in Small-cell Lung Cancer.
Journal: Cancer diagnosis & prognosis
Published: March 26, 2026
Dosimetric and clinical outcomes of stereotactic body radiotherapy for primary lung cancer: isocenter-based vs. volume-based prescription.
Journal: Frontiers in medicine
Published: December 08, 2025
Three-dimensional Conformal Radiation Planning Study for Limited-stage Small-cell Lung Cancer.
Journal: Cancer diagnosis & prognosis
Published: November 06, 2025
PET/CT findings and dose distribution during radiotherapy in T1N0M0-T2N0M0 glottic cancer.
Journal: Hellenic journal of nuclear medicine
Published: November 13, 2023
Association between PET-CT accumulation in the hypothalamic/pituitary regions and neuron-specific enolase/primary tumor in limited-stage small cell lung cancer: a case-controlled retrospective study.
Journal: EJNMMI reports
Published: October 06, 2023
The Preventive Effect of Melatonin on Radiation-Induced Oral Mucositis.
Journal: Cells
Published: August 10, 2023
Usefulness of Percutaneous Drainage in Determining the Causative Microorganism in Patients with Spondylodiscitis: A Retrospective Cross-Sectional Study.
Journal: Journal of the Belgian Society of Radiology
Published: March 04, 2023
Transcatheter arterial embolization for traumatic injury to the pharyngeal branch of the ascending pharyngeal artery: Two case reports.
Journal: World journal of clinical cases
Published: August 01, 2022
Brachiocephalic to left brachial vein thrombotic vasculitis accompanying mediastinal pancreatic fistula: A case report.
Journal: World journal of clinical cases
Published: May 24, 2022
Author Correction: TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice.
Journal: Scientific reports
Published: April 13, 2022
Tracheobronchial chondritis as an immune-related adverse event occurring during the administration of nivolumab for recurrent hypopharyngeal squamous cell carcinoma.
Journal: Ear, nose, & throat journal
Published: March 28, 2022
Last Updated: 09/26/2026